Acute Porphyria Drug Database

Monograph

S01GX02 - Levocabastine
Not porphyrinogenic
NP

Rationale
No significant systemic exposure.
Chemical description
Eye drops, 0,5 mg/mL, used in allergic conjunctivitis. Plasma concentration to low to give rise to systemic effects.
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.

Similar drugs
Explore alternative drugs in similar therapeutic classes S01G / S01GX or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Livocab · Livocab 0,5 mg/ml oogdruppels, suspensie
Belgium
Livostin · Livostin 0.5 mg/ml (PI Pharma) collyre susp. flac. compte-gouttes · Livostin 0.5 mg/ml collyre susp.
United Kingdom
Livostin · Livostin 0.5mg/ml eye drops · Livostin Direct · Livostin Direct 0.5mg/ml eye drops
Denmark
Benaliv
Norway
Livostin
Luxembourg
LIVOSTIN
Iceland
Livostin
Finland
Livostin
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙